Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...

Individuals with vitiligo did not display a significantly increased risk for cancer compared with the general population, according to a study.“Traditionally linked to other autoimmune diseases, ...

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

KRISTOPHER WENTZEL ONCOLOGY Hematologist Oncologist The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate Dr. Kristopher Wentzel leads the ...

Sequential gemcitabine docetaxel is increasingly viewed as a valid option for BCG unresponsive non-muscle-invasive bladder cancer (NMIBC).

Jan. 30—"When the people lead, the leaders follow." That's the mantra being followed by environmental and community advocates who believe more action is needed to protect the public from a potentially ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will particip ...

CARLSBAD, Calif. - Tyra Biosciences , Inc. (NASDAQ:TYRA), a biotech firm specializing in precision medicines targeting Fibroblast Growth Factor Receptor (FGFR) biology, today announced the appointment ...

ImmunityBio shares surged as much as 14% on Wednesday, reaching their highest level in nearly seven weeks while lifting ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

Debate over labeling certain cancers as 'benign' or 'premalignant' instead of 'cancer' due to stigma and fear. Experts weigh in on potential impact ...